Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis 2013-2018 and Forecast 2019-2024

March 2019 | 83 pages | ID: G20FCD46372EN
99Strategy

Abstracts

SNAPSHOT

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Exenatied
• Liraglutide
• Lixisenatide
• Albiglutide
• Dulaglutide

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Novo Nordisk
• AstraZeneca
• Eli Lily
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Hospital
• Pharmacy
• Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
• Asia-Pacific (China, India, Japan, Southeast Asia etc.)
• South America (Brazil, Argentina etc.)
• Middle East & Africa (Saudi Arabia, South Africa etc.)

Contents

1 INDUSTRY OVERVIEW

1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
  1.1.1 Overview
  1.1.2 Development of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Market Segment
  1.2.1 Upstream
  1.2.2 Downstream
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET BY TYPE

3.1 By Type
  3.1.1 Exenatied
  3.1.2 Liraglutide
  3.1.3 Lixisenatide
  3.1.4 Albiglutide
  3.1.5 Dulaglutide
3.2 Market Size
3.3 Market Forecast

4 MAJOR COMPANIES LIST

4.GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS NOVO NORDISK (COMPANY PROFILE, SALES DATA ETC.)

4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.3 Eli Lily (Company Profile, Sales Data etc.)
4.4 GSK (Company Profile, Sales Data etc.)
4.5 Sanofi (Company Profile, Sales Data etc.)
4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.7 Amylin (Company Profile, Sales Data etc.)

5 MARKET COMPETITION

5.1 Company Competition
5.2 Regional Market by Company

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Hospital
  6.1.2 Demand in Pharmacy
  6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast

7 REGION OPERATION

7.1 Regional Production
7.2 Regional Market
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
    7.3.1.2 by Country (U.S., Canada, Mexico)
  7.3.2 Europe
    7.3.2.1 Overview
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  7.3.4 South America
    7.3.4.1 Overview
    7.3.4.2 by Country (Brazil, Argentina etc.)
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel

9 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Upstream Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Application Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2013-2024, by Application, in USD Million
Table Major Company List of Exenatied
Table Major Company List of Liraglutide
Table Major Company List of Lixisenatide
Table Major Company List of Albiglutide
Table Major Company List of Dulaglutide
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2013-2018, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2013-2018, by Type, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2019-2024, by Type, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2019-2024, by Type, in Volume
Table Novo Nordisk Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lily Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amylin Overview List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Business Operation of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue 2013-2018, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share, by Company, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume 2013-2018, by Company, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2019-2024, by Application, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Demand Forecast 2019-2024, by Application, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2013-2018, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Production 2013-2018, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2013-2018, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2013-2018, by Region, in USD Million
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market 2013-2018, by Region, in Volume
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share 2013-2018, by Region, in Volume
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in USD Million
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in Volume
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in USD Million
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in Volume
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in USD Million
Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size 2013-2018, by Country, in Volume
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2019-2024, by Region, in USD Million
Table Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

List Of Figures

LIST OF FIGURES

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2013-2018, by Type, in USD Million
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2013-2018, by Type, in Volume
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2018
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Market Concentration, in 2018
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists MMarket Concentration, in 2018
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2018
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration, in 2018
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2013-2018, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Hospital, 2013-2018, in Volume
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2013-2018, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Pharmacy, 2013-2018, in Volume
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2013-2018, in USD Million
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Demand in Others, 2013-2018, in Volume
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in USD Million
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in Volume
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in USD Million
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in Volume
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in USD Million
Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview